{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:57:25Z","timestamp":1781845045175,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejso.2025.110377","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T22:28:58Z","timestamp":1754778538000},"page":"110377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing the pathological diagnosis of diffuse malignant peritoneal mesothelioma"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4311-4430","authenticated-orcid":false,"given":"F.L.","family":"Nava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3116-277X","authenticated-orcid":false,"given":"S.","family":"Kusamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Shimonovitz-Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8606-7382","authenticated-orcid":false,"given":"T.","family":"Cavalleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5442-2642","authenticated-orcid":false,"given":"D.","family":"Baratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Guaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6369-2356","authenticated-orcid":false,"given":"A.D.","family":"Cabras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9859-836X","authenticated-orcid":false,"given":"G.","family":"Colletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4549-1395","authenticated-orcid":false,"given":"M.","family":"Deraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Milione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejso.2025.110377_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2017 update of the consensus statement from the international mesothelioma interest group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.ejso.2025.110377_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers15030662","article-title":"Diagnostic and therapeutic pathway in diffuse malignant peritoneal mesothelioma","volume":"15","author":"Kusamura","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ejso.2025.110377_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010229","article-title":"Contemporary trends in malignant peritoneal mesothelioma: incidence and survival in the United States","volume":"15","author":"Calthorpe","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ejso.2025.110377_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040942","article-title":"Incidence, survival analysis and future perspective of primary peritoneal mesothelioma (PPM): a population-based study from SEER database","volume":"14","author":"Ullah","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ejso.2025.110377_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejso.2020.02.011","article-title":"Peritoneal mesothelioma : PSOGI\/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"47","author":"Kusamura","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.ejso.2025.110377_bib6","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/cncr.32870","article-title":"The Chicago consensus on peritoneal surface malignancies: management of peritoneal mesothelioma","volume":"126","author":"Schuitevoerder","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2025.110377_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejca.2016.06.002","article-title":"Diffuse malignant peritoneal mesothelioma: evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE database: multi-institutional retrospective study","volume":"65","author":"Kepenekian","year":"2016","journal-title":"Eur J Cancer"},{"issue":"9","key":"10.1016\/j.ejso.2025.110377_bib8","doi-asserted-by":"crossref","first-page":"961","DOI":"10.6004\/jnccn.2023.0045","article-title":"Mesothelioma: peritoneal, version 2.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Ettinger","year":"2023","journal-title":"J Natl Compr Cancer Netw"},{"issue":"5","key":"10.1016\/j.ejso.2025.110377_bib9","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1245\/s10434-015-4962-9","article-title":"The role of Ki-67 and pre-cytoreduction parameters in selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"23","author":"Kusamura","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2025.110377_bib10","article-title":"Stard 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"issue":"13","key":"10.1016\/j.ejso.2025.110377_bib11","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1245\/s10434-015-4498-z","article-title":"Immunohistochemical evaluation of minichromosome maintenance protein 7 (MCM7), topoisomerase II\u03b1, and Ki-67 in diffuse malignant peritoneal mesothelioma patients using tissue microarray","volume":"22","author":"Deraco","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2025.110377_bib12","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2213-8587(18)30288-2","article-title":"Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3\u00b76 million adults in the UK","volume":"6","author":"Bhaskaran","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.ejso.2025.110377_bib13","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12885-023-10871-w","article-title":"Prognostic role of CD74, CD10 and Ki-67 immunohistochemical expression in patients with diffuse malignant peritoneal mesothelioma: a retrospective study","volume":"23","author":"Liang","year":"2023","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2025.110377_bib15","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/PAS.0000000000002196","article-title":"Ki-67 proliferation index is associated with tumor grade and survival in pleural epithelioid mesotheliomas","volume":"48","author":"Galeano","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"23","key":"10.1016\/j.ejso.2025.110377_bib16","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1002\/cncr.32416","article-title":"Diagnostic value of biopsy sampling in predicting histology in patients with diffuse malignant pleural mesothelioma","volume":"125","author":"Chirieac","year":"2019","journal-title":"Cancer"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325008054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325008054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T19:40:12Z","timestamp":1759002012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325008054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0748798325008054"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110377","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing the pathological diagnosis of diffuse malignant peritoneal mesothelioma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110377","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110377"}}